Skip to main content
. 2012 Apr 16;42(1):97–110. doi: 10.1093/ije/dys066

Table 3.

ALSPAC mother's summary of measurements

Self-reported questionnaire measures
From pregnancy to 20 years postnatal; numbers with data vary from ∼5000 to 13 700; more than 9467 have completed at least 10 of the 18 questionnaires to date.a
  • Demographics: Age, marital status, socio-economic position, household composition, ethnicity, parity

  • Personality: Questionnaire assessment of personality, attitudes, behaviours, feelings about becoming pregnant and about becoming a mother

  • Life course characteristics: Retrospective report of their early life exposures and characteristics, including birthweight, parental occupations, childhood housing conditions

  • Health-related behaviours: Smoking, alcohol, diet, physical activity, illegal drug use

  • Health:
    • ○ Mental health (repeatedly assessed depression and anxiety by using validated scales);
    • ○ Reproductive health [repeatedly assessed pregnancies (including their outcomes and pregnancy complications), contraception, hormone replacement, menstrual patterns, cessation of menstruation, hysterectomy/oophorectomy and in 2011 validated questions for identification of those with polycystic ovary syndrome, stress and urge incontinence]
    • ○ Cardiometabolic health (repeatedly assessed family history, own history of diagnosis of hypertension, diabetes, high cholesterol, since 2010 Rose angina and peripheral vascular disease questionnaires and questions about diagnoses of angina and myocardial infarction and of experience of angioplasty or coronary artery by-pass)
    • ○ Musculoskeletal health [repeatedly assessed diagnosis of arthritis (including type and joints affected), since 2008 asked about doctor diagnosis of osteoporosis, falls and fractures]
    • ○ Respiratory health (repeatedly asked about diagnoses and symptoms of asthma and bronchitis)
    • ○ Medication use (repeatedly asked to report about names, dosage, frequency and reason of prescribed and over-the-counter medication)
    • ○ Childhood health (retrospective report of hospital admissions, diagnoses, injuries and illnesses in childhood)
    • ○ Family health [retrospective report of whether parents remain alive, age and cause of death if they had died, family history of specific conditions (e.g. cardiovascular disease, diabetes, cancer)]
Obstetric data abstracted from medical records
Available on 13 706 womena
  • Repeat measurements of weight [median (IQR) measurements per woman: 12 (9–13)], blood pressure [median (IQR): 13 (11–16)], protein- and glycos-uria [median (IQR): 12 (9–14)], peripheral oedema [median (IQR): 13 (11–16)], haemoglobin [median (IQR): 3 (2–3)].

  • Derived (from repeat blood pressure and proteinuria measurements and questionnaire data) hypertensive disorders of pregnancy (pre-existing hypertension, gestational hypertension, pre-eclampsia, pre-clampsia superimposed on pre-existing hypertension)

  • Medical record recorded diagnoses of gestational diabetes, anaemia and other complications of pregnancy

  • Results of booking clinic blood tests—blood group, haemoglobin, rubella immunity

  • Whether amniocentesis or chorionic villus sampling was undertaken

  • Hospital admissions (whether or not any occurred on the total sample; details of dates, length of stay and reason available on 8369)

  • Results of ultrasound examinations (on 8369)

  • Method and place of delivery

  • Placental weight (available on 5769)

  • Postnatal health (presence of anaemia on the total sample; details of other conditions and treatments up to 14 days postnatal (or when were discharged from care) available on 8369)

Opportunistic clinic assessments
Completed on mothers when they attended Focus assessments with their index child and when staff and resources allowed these assessments; numbers and time points vary and are detailed by each measure
  • Anthropometry: At 12–13 years postnatal: weight (N = 439), standing height (N = 439). At 15–16 years postnatal: weight (N = 2412), standing height (N = 2412), seated height (N = 1635), waist (N = 1638), hip (N = 1637), arm (N = 1641) and head (N = 1641) circumference

  • Bioimpedance for percent body fat: At 12–13 years postnatal (N = 439). At 15–16 years postnatal (N = 2405)

  • Dual-energy X-ray Absorptiomtry (DXA) whole body and hip scan for fat, lean and bone mass: At 15–16 years postnatal (N = 2086)

  • Systolic and diastolic blood pressure and pulse rate: At assessment 12–13 years postnatal (N = 389). At 13–14 years postnatal (N = 4173). At 15–16 postnatal (N = 3924)

  • Emotional well-being and responses: Locus of Control at 12–13 years postnatal (N = 4069) and at 15–16 years postnatal (N = 4490). Development And Well-Being Assessment (DAWBA) at 15–16 years postnatal (N = 4242)

  • Cognitive function: Theory Of Mind (TOM) assessment at 13–14 years postnatal (N = 4913). Wechsler Abbreviated Scale of Intelligence (WASI) at 15–16 years postnatal (N = 3900)

  • Visual acuity and retinal photography at 15–16 years postnatal (N = 1005)

FoM1 follow-up clinic assessment
Completed 2009–11, N = 4834a
  • Anthropometry: weight, height, waist, hip and head circumference

  • DXA whole body and hip scan for fat, lean and bone mass

  • Seated and standing systolic and diastolic blood pressure and pulse rate

  • Carotid intima-media thickness and arterial stiffness

  • Brief computer-completed questionnaire collecting information on menstrual cycle (including date of last menstrual period), contraception, use of hormone replacement, hysterectomy/oophorectomy, current use of any medications (including dosage, frequency and reason), allergies

  • Fasting blood samples for storage and assays of haemoglobin, glucose, insulin, pro-insulin, lipids, C-reactive protein, sex hormones and for DNA in any women on whom a previous sample was not available

Funded and ongoing future FoM2–4 clinics
These data will be collected on 3000 women who were pre- or peri-menopausal at the time of FoM1 and likely to change through one or more of the stages of the menopausal transition over the next 5 years; FoM2 began in August 2011 and to date (February 2012) approximately 700 women have attended and completed the assessments
  • Anthropometry: weight, height, waist, hip and head circumference

  • DXA whole body and hip scan for fat, lean and bone mass

  • Peripheral quantitative computer tomography of radius to assess bone structure

  • Seated and standing systolic and diastolic blood pressure and pulse rate

  • Cognitive function: logical memory test, backwards digital span, spot the word test, digital symbol coding

  • Physical capability: hand-grip strength, chair rise, balance and 3-m walk test

  • Physical activity: accelerometer assessed

  • Brief computer-completed questionnaire collecting information on menstrual cycle (including date of last menstrual period), contraception, use of hormone replacement, hysterectomy/oophorectomy, current use of any medications (including dosage, frequency and reason), allergies

  • Fasting blood samples for storage and assays of haemoglobin, glucose, insulin, pro-insulin, lipids, C-reactive protein, sex hormones and for DNA in any women on whom a previous sample was not available

Record linkage
All recruited women who provided permission have been linked to the National Health Service (NHS) Central Register, which provides data on the following.
  • Death (including underlying and contributing causes and date)

  • Cancer (including type, site and date of registration (approximate date of diagnosis)

  • Emigration (out of the UK)

aNumbers given for a particular questionnaire or focus follow-up visit assessment refer to the number who completed at least some of the questions/measurements. For individual measurements, the N will vary but only by small amounts. Where it is markedly different (e.g. for placental weights in the obstetric data abstraction), this is noted.

Environmental toxin data have also been collected from households and samples in ALSPAC; these are detailed in the companion cohort profile focusing on the offspring.2